FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. What is described is a haemostatic composition containing a biologically absorbable material and hyaluronic acid or a derivative thereof. There are described methods for preparing the given compositions, and there are described the applications of the given compositions. Particularly, the method for preparing the above haemostatic composition involves the dry heat treatment at temperature 110 to 200°C.
EFFECT: compositions exhibit the enhanced haemostatic properties.
68 cl, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
| HAEMOSTATIC SPRAYS AND COMPOSITIONS | 2005 |
|
RU2377022C9 |
| DRY COMPOSITION COMPRISING EXTRUSION ENHANCER | 2014 |
|
RU2678592C1 |
| DRY HAEMOSTATIC COMPOSITION | 2013 |
|
RU2636240C2 |
| HAEMOSTATIC SPONGE | 2011 |
|
RU2562569C2 |
| DRY COMPOSITION FOR USE IN HAEMOSTASIS AND WOUND HEALING | 2015 |
|
RU2715235C2 |
| FAST-ACTING SEALING AND THE METHODS OF ITS APPLICATION AND PRODUCTION | 2007 |
|
RU2442612C2 |
| HAEMOSTASIS COMPOSITION INCLUDING A MATRIX BASED ON A CROSS-LINKING HYALURONIC ACID DERIVATIVE | 2017 |
|
RU2740191C2 |
| APPLICATION HEMOSTATIC MATERIAL AND METHOD OF ITS PRODUCTION | 2020 |
|
RU2810165C1 |
| PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
